ADAPTIVE BIOTECHNOLOGIES CORPORATION (ADPT) Revenue 2017–2025
ADAPTIVE BIOTECHNOLOGIES CORPORATION (ADPT) annual revenue history from SEC filings — each fiscal year as reported, with year-over-year change.
$277.0MFY2025 · since FY2017: $38.4M → $277.0M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $277.0M | +54.8% |
| FY2024 | $179.0M | +5.1% |
| FY2023 | $170.3M | -8.1% |
| FY2022 | $185.3M | +20.1% |
| FY2021 | $154.3M | +56.9% |
| FY2020 | $98.4M | +15.6% |
| FY2019 | $85.1M | +52.8% |
| FY2018 | $55.7M | +44.8% |
| FY2017 | $38.4M | — |
Source: SEC XBRL filings · For reference only · Not investment advice